Amedisys Inc. (AMED)

NASDAQ: AMED · IEX Real-Time Price · USD
91.04
-0.21 (-0.23%)
Nov 25, 2022 1:00 PM EDT - Market closed
-0.23%
Market Cap 2.96B
Revenue (ttm) 2.22B
Net Income (ttm) 120.94M
Shares Out 32.48M
EPS (ttm) 3.86
PE Ratio 23.59
Forward PE 16.92
Dividend n/a
Ex-Dividend Date n/a
Volume 211,343
Open 91.25
Previous Close 91.25
Day's Range 89.87 - 91.29
52-Week Range 83.01 - 179.91
Beta 0.99
Analysts Buy
Price Target 132.38 (+45.4%)
Earnings Date Oct 27, 2022

About AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides... [Read more]

Industry Health Care Providers & Services
Founded 1982
CEO Paul Kusserow
Employees 21,000
Stock Exchange NASDAQ
Ticker Symbol AMED
Full Company Profile

Financial Performance

In 2021, Amedisys's revenue was $2.21 billion, an increase of 6.88% compared to the previous year's $2.07 billion. Earnings were $209.07 million, an increase of 13.87%.

Financial Statements

Analyst Forecast

According to 22 analysts, the average rating for AMED stock is "Buy." The 12-month stock price forecast is 132.38, which is an increase of 45.41% from the latest price.

Price Target
$132.38
(45.41% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Amedisys Names Scott Ginn Acting Chief Operating Officer

BATON ROUGE, La., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, names Scott Ginn, Executive Vice Presid...

3 days ago - GlobeNewsWire

Amedisys Confirms Full Year Guidance

BATON ROUGE, La. , Nov. 17, 2022 /PRNewswire/ -- Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced a leadership change that President and Chief Executive Officer, Chris Gerard, wi...

1 week ago - PRNewsWire

Amedisys Announces CEO Departure

Paul Kusserow returns as Chairman and CEO BATON ROUGE, La. , Nov. 17, 2022 /PRNewswire/ -- Today, the Board of Directors of Amedisys, Inc. (NASDAQ: AMED) announced that President and Chief Executive Off...

1 week ago - PRNewsWire

Amedisys Statement on CY 2023 Home Health Final Rule

BATON ROUGE, La., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, issued the following statement ...

3 weeks ago - GlobeNewsWire

Amedisys (AMED) Q3 Earnings Miss Estimates, Guidance Cut

Within Amedisys (AMED) Home Health and Hospice, the reinstatement of sequestration reduces growth in Q3.

3 weeks ago - Zacks Investment Research

Amedisys (AMED) Misses Q3 Earnings and Revenue Estimates

Amedisys (AMED) delivered earnings and revenue surprises of -7.26% and 3.41%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

4 weeks ago - Zacks Investment Research

Amedisys Reports Third Quarter 2022 Financial Results and Updates 2022 Guidance

BATON ROUGE, La., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2022.

4 weeks ago - GlobeNewsWire

3 Stocks to Watch From the Pandemic-Hit Outpatient Home Health Industry

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. AMED, ADUS and HNGR are wel...

Other symbols: ADUSHNGR
1 month ago - Zacks Investment Research

Amedisys Welcomes Adam Holton as Chief People Officer

BATON ROUGE, La., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice, personal care and high-acuity care company, announced today that Adam Holton will join ...

1 month ago - GlobeNewsWire

Here's Why Investors Should Retain Amedisys (AMED) Stock for Now

Investors are optimistic about Amedisys' (AMED) better-than-expected earnings and notable buyouts.

2 months ago - Zacks Investment Research

Mount Sinai Health System Partners with Contessa to Create Mount Sinai at Home, a Home-Based Care Continuum

Mount Sinai at Home provides home health, hospitalization at home, rehabilitation at home and palliative care at home to patients in the New York metropolitan area Mount Sinai at Home provides home heal...

3 months ago - GlobeNewsWire

Amedisys (AMED) Q2 Earnings Surpass Estimates, Margins Down

Lower utilization of home health benefit, primarily driven by lesser total discharges to post-acute settings, hampers Amedisys' (AMED) Q2 revenues.

3 months ago - Zacks Investment Research

Amedisys (AMED) Q2 Earnings Beat Estimates

Amedisys (AMED) delivered earnings and revenue surprises of 19.51% and 4.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Amedisys Reports Second Quarter 2022 Financial Results and Updates 2022 Revenue Guidance

BATON ROUGE, La., July 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2022.

3 months ago - GlobeNewsWire

Earnings Preview: Amedisys (AMED) Q2 Earnings Expected to Decline

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

Amedisys Announces Second Quarter 2022 Earnings Release and Conference Call Date

BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the sec...

4 months ago - GlobeNewsWire

Amedisys' (AMED) New Tie Up to Boost At-Home Patient Care

Amedisys (AMED) strengthens its Home Health and Hospice business reach by partnering with Memorial Hermann.

4 months ago - Zacks Investment Research

Memorial Hermann and Contessa Partner to Provide Patients New At-Home Care Options

This partnership gives patients options of where to receive inpatient, rehabilitation, and palliative care This partnership gives patients options of where to receive inpatient, rehabilitation, and pall...

5 months ago - GlobeNewsWire

Amedisys (AMED) Contessa's New JV Broadens At-Home Care Range

Amedisys' (AMED) latest initiative aims at providing patients with a high-quality continuum of care in the home.

5 months ago - Zacks Investment Research

Amedisys Releases Inaugural Environmental, Social and Governance (ESG) Report

BATON ROUGE, La., June 09, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, has released its first Environmental, S...

5 months ago - GlobeNewsWire

Baylor Scott & White Health and Contessa Announce Partnership to Create New Model of At-Home Care for Patients

Partnership will create a continuum of at-home care that encourages patient choice, reduces costs and improves outcomes Partnership will create a continuum of at-home care that encourages patient choice...

5 months ago - GlobeNewsWire

Amedisys (AMED) Down 11% Since Last Earnings Report: Can It Rebound?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

Here's Why You Should Retain Amedisys (AMED) Stock for Now

Investors are optimistic about the robust performances of Amedisys' (AMED) Home Health and Hospice segments.

6 months ago - Zacks Investment Research

Amedisys to Present at Multiple Healthcare Conferences in June

BATON ROUGE, La., May 25, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Chris Gerard, Presi...

6 months ago - GlobeNewsWire

Amedisys (AMED) New Buyouts Aid Growth, Margin Pressure Stays

Amedisys' (AMED) newly-formed high-acuity care segment experiences solid momentum in the first quarter.

6 months ago - Zacks Investment Research